Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.

doi:10.1038/s41564-021-01041-4

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.

Nature microbiology - 1 Feb 2022

Servellita Venice, Morris Mary Kate, Sotomayor-Gonzalez Alicia, Gliwa Amelia S, Torres Erika, Brazer Noah, Zhou Alicia, Hernandez Katherine T, Sankaran Madeline, Wang Baolin, Wong Daniel, Wang Candace, Zhang Yueyuan, Reyes Kevin R, Glasner Dustin, Deng Xianding, Streithorst Jessica, Miller Steve, Frias Edwin, Rodgers Mary, Cloherty Gavin, Hackett John, Hanson Carl, Wadford Debra, Philip Susan, Topper Scott, Sachdev Darpun, Chiu Charles Y

Abstract excerpt

Associations between vaccine breakthrough cases and infection by different SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analysed SARS-CoV-2 whole-genome sequences and viral loads from 1,373 persons with COVID-19 from the San Francisco Bay Area from 1 February to 30 June 2021, of which 125 (9.1%) were vaccine breakthrough infections. Vaccine breakthrough infections were more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to COVID-19

Share to COVID-19 Vaccines

Share to San Francisco

Share to SARS-CoV-2

Share to Vaccination

Share to Whole Genome Sequencing

Source

Open in PubMed

Identifiers

PMID: 35013591
DOI: 10.1038/s41564-021-01041-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.PMID 35013591Read ↗

Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.Semantic proximity Read ↗

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine typeSemantic proximity Read ↗

SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021Semantic proximity Read ↗

SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccinationSemantic proximity Read ↗

COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational varianceSemantic proximity Read ↗

Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort studySemantic proximity Read ↗

Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients.Semantic proximity Read ↗

COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicronSemantic proximity Read ↗

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.Semantic proximity Read ↗

Increased vaccine sensitivity of an emerging SARS-CoV-2 variantSemantic proximity Read ↗

A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine EffectivenessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.